Statement from Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO)Continue reading
Category Archives: AZBio News
OncoMyx Therapeutics Appoints Dr. Charles Baum Chairperson of Board of Directors
PHOENIX, November 6, 2020 – OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, today announced the appointment of Charles (Chuck) M. Baum, M.D., Ph.D., as chairperson of the company’s board of directors. Dr. Baum is currently president and chief executive officer of Mirati Therapeutics, which develops novel therapeutics that target the genetic and immunologic drivers of cancer. He has more than 25 years of experience leading the clinical development of precision oncology drugs, including axitinib (Inlyta®), crizotinib (Xalkori®), sunitinib (Sutent®), and temozolomide (Temodar®).Continue reading
AZBio Members Win Big at the Governor’s Celebration of Innovation
Additive Implants, Avery Therapeutics, BD Peripheral Intervention, and the Biodesign Institute at ASU, were were honored as winners of 2020 Governor’s Celebration of Innovation (GCOI) Awards. Awards to individuals were bestowed on Fletcher J. McCusker, UAVenture Capital, and Dr. Betsy Cantwell, The University of Arizona.
Pediatric IBD Foundation, ImproveCareNow, C-Path to Establish the Children’s Registry for the Advancement of Therapeutics
TUCSON, Ariz., November 5, 2020 — The Pediatric IBD Foundation, ImproveCareNow, and the Critical Path Institute (C-Path) are proud to announce a collaboration establishing the Children’s Registry for the Advancement of Therapeutics (CREATE™). CREATE™ is a drug-agnostic safety registry designed to support the completion of global post-marketing safety requirements, as well as collect safety information on all therapies used in pediatric IBD patients.
HTG Demonstrates Technical Feasibility for a Whole Transcriptome Panel Using HTG EdgeSeq Technology
TUCSON, Ariz., Nov. 02, 2020 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the completion of proof of concept for a whole transcriptome panel using the HTG EdgeSeq technology, and release of a White Paper illustrating the feasibility and performance of this prototype panel relative to RNA sequencing (RNA-Seq). As previously discussed, HTG is developing a whole transcriptome panel utilizing the HTG EdgeSeq technology to measure approximately 20,000 mRNA targets, with a planned RUO launch in mid-2021.Continue reading
TGen Appoints Dr. Sunil Sharma Physician-in-Chief
New title reflects growing role and responsibility in helping guide TGen research across multiple scientific disciplines
NeoLight Raises $7M to Enable Home-Based Neonatal Care
PHOENIX, AZ / ACCESSWIRE / October 27, 2020 / Thank Covid-19: These days, hospital stays are risky, and space is at a premium. To get newborns and their parents home sooner, NeoLight, an Arizona State University spin-out, has raised $7 million to facilitate in-home neonatal care.
BIO Announces New Strategic Vision
BIO announces new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds
FDA Awards C-Path Grant to Use Real-World Data to Generate Real-World Evidence in Neonates
Pilot project will include the development of a Real-World Data and Analytics Platform
TUCSON, Ariz., October 27, 2020 — Arizona-based Critical Path Institute (C-Path) is pleased to announce it has been awarded a multi-year grant by the U.S. Food and Drug Administration (FDA) to advance standards and methodologies designed to generate real-world evidence (RWE) from real-world data (RWD) through a neonatal pilot project through the International Neonatal Consortium (INC).Continue reading
HybridChart Announces Partnership with PointClickCare
Partnership to Integrate HybridChart’s Rounding and Workflow Solution with PointClickCare’s EHR PlatformContinue reading